AAAAAA

   
Results: 1-9 |
Results: 9
CONTROL OF ORAL ANTICOAGULATION IN PATIENTS WITH THE ANTIPHOSPHOLIPIDSYNDROME - INFLUENCE OF THE LUPUS ANTICOAGULANT ON INTERNATIONAL NORMALIZED RATIO
Authors: ROBERT A LEQUERREC A DELAHOUSSE B CARON C HOUBOUYAN L BOUTIERE B HORELLOU MH REBER G SIE P
Citation: A. Robert et al., CONTROL OF ORAL ANTICOAGULATION IN PATIENTS WITH THE ANTIPHOSPHOLIPIDSYNDROME - INFLUENCE OF THE LUPUS ANTICOAGULANT ON INTERNATIONAL NORMALIZED RATIO, Thrombosis and haemostasis, 80(1), 1998, pp. 99-103
MONITORING HEPARIN-THERAPY USING ACTIVATED PARTIAL THROMBOPLASTIN TIME - RESULTS OF A MULTICENTER TRIAL ESTABLISHING THE THERAPEUTIC RANGE FOR SILIMAT, A REAGENT WITH HIGH-SENSITIVITY TO HEPARIN
Authors: TOULON P BOUTIERE B HORELLOU MH TRZECIAK MC SAMAMA MM
Citation: P. Toulon et al., MONITORING HEPARIN-THERAPY USING ACTIVATED PARTIAL THROMBOPLASTIN TIME - RESULTS OF A MULTICENTER TRIAL ESTABLISHING THE THERAPEUTIC RANGE FOR SILIMAT, A REAGENT WITH HIGH-SENSITIVITY TO HEPARIN, Thrombosis and haemostasis, 80(1), 1998, pp. 104-108
VALIDATION PROTOCOL OF ANALYTICAL HEMOSTASIS SYSTEMS - MEASUREMENT OFANTI-XA ACTIVITY OF LOW-MOLECULAR-WEIGHT HEPARINS
Authors: HOUBOUYAN L BOUTIERE B CONTANT G DAUTZENBERG MD FIEVET P POTRON G VASSAULT A GOURMELIN Y
Citation: L. Houbouyan et al., VALIDATION PROTOCOL OF ANALYTICAL HEMOSTASIS SYSTEMS - MEASUREMENT OFANTI-XA ACTIVITY OF LOW-MOLECULAR-WEIGHT HEPARINS, Clinical chemistry, 42(8), 1996, pp. 1223-1230
INR STANDARDIZATION BY THE CALIBRATED PLASMA PROCEDURE (CPP)
Authors: HOUBOUYAN L BONVARLET MN COMBY S SANVERT M RAGEADE C DUPUY G GOQUEL A BOUTIERE B CARMAGNOL F DROULLE C HOUBOUYAN L LAVENNE E MARION S POTRON G
Citation: L. Houbouyan et al., INR STANDARDIZATION BY THE CALIBRATED PLASMA PROCEDURE (CPP), Thrombosis and haemostasis, 73(6), 1995, pp. 1238-1238
ANTIPHOSPHOLIPID ANTIBODIES AND HEMOSTATIC-PROPERTIES OF ENDOTHELIAL-CELL
Authors: SAMPOL J BOUTIERE B ARNOUX D BERTRAND JJ GEORGE F
Citation: J. Sampol et al., ANTIPHOSPHOLIPID ANTIBODIES AND HEMOSTATIC-PROPERTIES OF ENDOTHELIAL-CELL, Pathologie et biologie, 42(8), 1994, pp. 794-794
PLASMA THROMBOMODULIN IN ORTHOTOPIC LIVER-TRANSPLANTATION
Authors: BOUTIERE B ARNOUX D BOFFA MC SAMSON D LETREUT YP SAMPOL J
Citation: B. Boutiere et al., PLASMA THROMBOMODULIN IN ORTHOTOPIC LIVER-TRANSPLANTATION, Transplantation, 58(12), 1994, pp. 1352-1355
ANTIPHOSPHOLIPID ANTIBODIES
Authors: BOUTIERE B ARNOUX D SAMPOL J
Citation: B. Boutiere et al., ANTIPHOSPHOLIPID ANTIBODIES, Annales de biologie clinique, 52(2), 1994, pp. 87-93
INDUCTION OF TISSUE FACTOR BY IGG ISOLATED FROM PATIENTS WITH LUPUS ANTICOAGULANT (LA) IN HUMAN ENDOTHELIAL-CELLS
Authors: BERTRAND JJ ARNOUX D BOUTIERE B SAMPOL J
Citation: Jj. Bertrand et al., INDUCTION OF TISSUE FACTOR BY IGG ISOLATED FROM PATIENTS WITH LUPUS ANTICOAGULANT (LA) IN HUMAN ENDOTHELIAL-CELLS, Thrombosis and haemostasis, 69(6), 1993, pp. 594-594
MONITORING TREATMENT WITH UNFRACTIONATED HEPARIN USING A NEW ACTIVATED PARTIAL THROMBOPLASTIN TIME (APTT) REAGENT - SILIMAT - PRELIMINARY-RESULTS OF A MULTICENTER TRIAL
Authors: TOULON P BOUTIERE B HORELLOU MH TRZECIAK MC SAMAMA MM
Citation: P. Toulon et al., MONITORING TREATMENT WITH UNFRACTIONATED HEPARIN USING A NEW ACTIVATED PARTIAL THROMBOPLASTIN TIME (APTT) REAGENT - SILIMAT - PRELIMINARY-RESULTS OF A MULTICENTER TRIAL, Thrombosis and haemostasis, 69(6), 1993, pp. 1121-1121
Risultati: 1-9 |